These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Susceptibility genes in thyroid autoimmunity. Ban Y; Tomer Y Clin Dev Immunol; 2005 Mar; 12(1):47-58. PubMed ID: 15712599 [TBL] [Abstract][Full Text] [Related]
28. Association between a C/T polymorphism in exon 33 of the thyroglobulin gene is associated with relapse of Graves' hyperthyroidism after antithyroid withdrawal in Taiwanese. Hsiao JY; Hsieh MC; Tien KJ; Hsu SC; Shin SJ; Lin SR J Clin Endocrinol Metab; 2007 Aug; 92(8):3197-201. PubMed ID: 17550957 [TBL] [Abstract][Full Text] [Related]
30. [Genetic and environmental factors in Graves disease. A review]. Brix TH; Kyvik KO; Hegedüs L Ugeskr Laeger; 1998 Jan; 160(5):616-21. PubMed ID: 9470466 [TBL] [Abstract][Full Text] [Related]
31. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Brix TH; Kyvik KO; Hegedüs L Thyroid; 1998 Jul; 8(7):627-34. PubMed ID: 9709918 [TBL] [Abstract][Full Text] [Related]
32. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Brix TH; Kyvik KO; Hegedüs L Thyroid; 1998 Aug; 8(8):727-34. PubMed ID: 9737369 [TBL] [Abstract][Full Text] [Related]
33. Graves' disease: Epidemiology, genetic and environmental risk factors and viruses. Antonelli A; Ferrari SM; Ragusa F; Elia G; Paparo SR; Ruffilli I; Patrizio A; Giusti C; Gonnella D; Cristaudo A; Foddis R; Shoenfeld Y; Fallahi P Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101387. PubMed ID: 32107168 [TBL] [Abstract][Full Text] [Related]
34. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity. Dittmar M; Kahaly GJ Thyroid; 2005 Mar; 15(3):239-50. PubMed ID: 15785243 [TBL] [Abstract][Full Text] [Related]
35. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients. Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640 [TBL] [Abstract][Full Text] [Related]
36. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819 [TBL] [Abstract][Full Text] [Related]
37. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. Tomer Y; Barbesino G; Keddache M; Greenberg DA; Davies TF J Clin Endocrinol Metab; 1997 May; 82(5):1645-8. PubMed ID: 9141566 [TBL] [Abstract][Full Text] [Related]
38. Generation of a transgenic animal model of hyperthyroid Graves' disease. Kim-Saijo M; Akamizu T; Ikuta K; Iida Y; Ohmori K; Matsubara K; Matsuda Y; Suzuki M; Matsuda F; Nakao K Eur J Immunol; 2003 Sep; 33(9):2531-8. PubMed ID: 12938229 [TBL] [Abstract][Full Text] [Related]
40. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy. Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]